COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,584 Articles (22,905 medRxiv, 8,679 bioRxiv)

Most recent first Previous |  Page 1088: Articles 10871-10880  | Next

Modeling and predicting the overlap of B- and T-cell receptor repertoires in healthy and SARS-CoV-2 infected individuals
Ruiz Ortega, M., Spisak, N., Mora, T., Walczak, A. M.
10.1101/2021.12.17.473105 — Posted: 2021-12-20
Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
Sheward, D. J., Kim, C., Ehling, R. A., Pankow, A., Castro Dopico, X., Martin, D. P., Reddy, S. T., Dillner, J., Karlsson Hedestam, G. B., Albert, J., Murrell, B.
10.1101/2021.12.19.473354 — Posted: 2021-12-20
Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
Boribong, B. P., LaSalle, T. J., Bartsch, Y. C., Ellett, F., Loiselle, M. E., Davis, J. P., Gonye, A. L. K., Hajizadeh, S., Kreuzer, J., Pillai, S., Haas, W., Edlow, A. G., Fasano, A., Alter, G., Irimia, D., Sade-Feldman, M., Yonker, L. M.
10.1101/2021.12.18.473308 — Posted: 2021-12-20
Pre-clinical evaluation of antiviral activity of nitazoxanide against Sars-CoV-2
Driouich, J.-S., Cochin, M., Touret, F., Petit, P.-R., Gilles, M., Moureau, G., Barthelemy, K., Laprie, C., Wattanakul, T., Chotsiri, P., Hoglund, R. M., Tarning, J., Escudie, F., Scandale, I., Chatelain, E., de Lamballerie, X., Solas, C., Nougairede, A.
10.1101/2021.12.17.473113 — Posted: 2021-12-20
Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.
Mogro, E. G., Bottero, D., Lozano, M. J.
10.1101/2021.12.17.472912 — Posted: 2021-12-20
Structure prediction of the druggable fragments in SARS-CoV-2 untranslated regions
Gumna, J., Antczak, M., Adamiak, R. W., Bujnicki, J. M., Chen, S.-J., Ding, F., Ghosh, P., Li, J., Mukherjee, S., Nithin, C., Pachulska-Wieczorek, K., Ponce-Salvatierra, A., Popenda, M., Sarzynska, J., Wirecki, T., Zhang, D., Zhang, S., Zok, T., Westhof, E., Szachniuk, M., Miao, Z., Rybarczyk, A.
10.1101/2021.12.17.473170 — Posted: 2021-12-20
SARS-COV-2 Omicron variant predicted to exhibit higher affinity to ACE-2 receptor and lower affinity to a larger range of neutralizing antibodies, using a rapid assessment platform
Zemla, A., Desautels, T., Lau, E., Zhu, F., Arrildt, K., Segelke, B., Sundaram, S., Faissol, D. M.
10.1101/2021.12.16.472843 — Posted: 2021-12-20
Emerging SARS-CoV-2 Variants of Concern: Spike Protein Mutational Analysis and Epitope for Broad Neutralization
Mannar, D., Saville, J. W., Sun, Z., Zhu, X., Marti, M. M., Srivastava, S. S., Berezuk, A. M., Zhou, S., Tuttle, K., Sobolewski, M. D., Kim, A., Treat, B. R., Mayrelle Da Silva Castanha, P., Jacobs, J. L., Barratt-Boyes, S. M., Mellors, J. W., Dimiter, D. S., Li, W., Subramaniam, S.
10.1101/2021.12.17.473178 — Posted: 2021-12-20
Insights into standards of care: dexamethasone and antibodies against COVID-19 in hamster models
Wyler, E., Adler, J. M., Eschke, K., Teixeira Alves, G., Peidli, S., Pott, F., Kazmierski, J., Michalik, L., Kershaw, O., Bushe, J., Andreotti, S., Pennitz, P., Abdelgawad, A., Postmus, D., Goffinet, C., Kreye, J., Reincke, S. M., Prüss, H., Blüthgen, N., Gruber, A. D., Kuebler, W. M., Witzenrath, M., Landthaler, M., Nouailles, G., Trimpert, J.
10.1101/2021.12.17.473180 — Posted: 2021-12-20
Disrupted Peyer's patch microanatomy in COVID-19 including germinal centre atrophy independent of local virus
Trevelin, S. C., Pickering, S., Todd, K., Bishop, C., Pitcher, M., Mesa, J. G., Montorsi, L., Spada, F., Petrov, N., Green, A., Shankar-Hari, M., Neil, S. J. D., Spencer, J.
10.1101/2021.12.17.473179 — Posted: 2021-12-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).